Openlane buys back stock worth USD 25 million in secondary offering deal
OPLN•Openlane repurchases shares in registered secondary offering
- Openlane bought back 727,590 shares in a registered secondary offering that closed Aug. 13, 2026.
- The repurchase price matched the underwriter’s purchase price paid to the selling stockholder.
- The transaction was part of an 8,000,000-share sale by an Apax-advised fund that raised about $274.9 million.
- No proceeds from the broader secondary sale went to Openlane.
Related News
Adial Pharmaceuticals CEO Cary Claiborne set to depart after Sept. 17 annual meeting; CDO Matthew Davidson slated to succeed
ADIL•
U.S. FDA Grants Accelerated Approval To Bristol Myers Squibb's First Celmod Therapy Zenbexus™, In Combination With Daratumumab And Hyaluronidase-Fihj And Dexamethasone (Zdd) For Patients With Multiple Myeloma, As Early As First Relapse
BMY•
